It’s an understatement to say that HIV is a monster of a disease state. I mean, who’s with me? So many drugs with so many mechanisms of action, it can be hard to keep track. If this sounds like you, struggling to understand the difference between NRTIs and NNRTIs (let alone where they fit into a treatment regimen) you’re not alone. Luckily, this guide right here was literally developed with you in mind. Because someone’s gotta make it make sense, right?
Read MoreDrug
Ibalizumab-uiyk
Indication
In combination with other antiretrovirals, Trogarzo is indicated for the treatment of HIV-1 in heavily treatment-experienced adults with multi-drug resistant HIV-1 who are failing their current therapy.
Read MoreWell, we're coming full circle here. Our epic series on HIV is nearing its coda. We've only got one "class" of HIV meds left to talk about.
The Entry Inhibitors.
Read MoreIntegrase Inhibitors (also known as IN Strand Transfer Inhibitors...or commonly abbreviated as INSTIs) first appeared on the market in 2007. This may come as a surprise to you, but their job is to inhibit the HIV enzyme Integrase.
What does Integrase do?
Read MoreNon-Nucleoside Reverse Transcriptase Inhibitors, or NNRTIs (pronounced like NRTIs, but with a stutter), are the next class of HIV drugs we will be covering.
What makes a NON-nucleoside as opposed to a regular old fashioned nucleoside reverse transcriptase inhibitor?
Read More